|
1
|
Westerlund E, Brandt L, Hovatta O, Wallén
H, Ekbom A and Henriksson P: Incidence of hypertension, stroke,
coronary heart disease, and diabetes in women who have delivered
after in vitro fertilization: A population-based cohort study from
Sweden. Fertil Steril. 102:1096–1102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Veloso HH: Incidence of sudden cardiac
death in congestive heart failure: Chagas disease versus systemic
arterial hypertension. Int J Cardiol. 175:175–176. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim W, Park CS, Kim HJ, Kim KH, An HM, Kim
YH, Lim CH, Kang WY, Hwang SH and Kim W: Hypertensive heart failure
associated with middle aortic syndrome reversed dramatically by
endovascular management. J Cardiovasc Ultrasound. 19:144–147. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maskali F, Poussier S, Louis H, Boutley H,
Lhuillier M, Thornton SN, Karcher G, Lacolley P and Marie PY:
Assessment of the early stage of cardiac remodeling of
spontaneously hypertensive heart failure rats using the
quantitative 3-dimensional analysis provided by acipimox-enhanced
FDG-PET. Int J Cardiovasc Imaging. 30:449–456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sosner P, Cabasson S, Hulin-Delmotte C,
Saulnier PJ, Gand E, Torremocha F, Piguel X, Miot A, Maréchaud R,
Herpin D, et al: Effect of Cornell product and other ECG left
ventricular hypertrophy criteria on various cardiovascular
endpoints in type 2 diabetic patients. Int J Cardiol. 175:193–195.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seto S: Left ventricular hypertrophy,
ischemic heart disease and the incidence of cardiovascular events
in Japanese high-risk hypertensive patients. Circ J. 73:1014–1015.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ibsen H, Olsen MH, Wachtell K,
Borch-Johnsen K, Lindholm LH and Mogensen CE: Reduction in
albuminuria translates to reduction in cardiovascular events in
hypertensive patients with left ventricular hypertrophy and
diabetes. J Nephrol. 21:566–569. 2008.PubMed/NCBI
|
|
8
|
Pai AU, Chakrapani M, Bhaskaran U and
Kamath P: Study of home-monitored night blood pressure and its
correlation with left ventricular hypertrophy in treatment-naive
hypertensive patients. Singapore Med J. 53:95–98. 2012.PubMed/NCBI
|
|
9
|
Nathwani D, Reeves RA, Marquez-Julio A and
Leenen FH: Left ventricular hypertrophy in mild hypertension:
correlation with exercise blood pressure. Am Heart J. 109:386–387.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Simone G, Pasanisi F and Contaldo F:
Link of nonhemodynamic factors to hemodynamic determinantsof left
ventricular hypertrophy. Hypertension. 38:13–18. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bauwens FR, Duprez DA, De Buyzere ML, De
Backer TL, Kaufman JM, Van Hoecke J, Vermeulen A and Clement DL:
Influence of the arterial blood pressure and nonhemodynamic factors
on left ventricular hypertrophy in moderate essential hypertension.
Am J Cardiol. 68:925–929. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rateri DL, Howatt DA, Moorleghen JJ,
Charnigo R, Cassis LA and Daugherty A: Prolonged infusion of
angiotensin II in apoE(−/−)mice promotes macrophage recruitment
with continued expansion of abdominal aortic aneurysm. Am J Pathol.
179:1542–1548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ismahil MA and Prabhu SD: Cardiac immune
cell remodeling after myocardial infarction. J Mol Cell Cardiol.
62:142–143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee AA and McCulloch AD: Multiaxial
myocardial mechanics and extracellular matrix remodeling:
Mechanochemical regulation of cardiac fibroblast function. Adv Exp
Med Biol. 430:227–240. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ngu JM, Teng G, Meijndert HC, Mewhort HE,
Turnbull JD, Stetler-Stevenson WG and Fedak PW: Human cardiac
fibroblast extracellular matrix remodeling: dual effects of tissue
inhibitor of metalloproteinase-2. Cardiovasc Pathol. 23:335–343.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Orme S, Ralph SG, Birchall A,
Lawson-Matthew P, McLean K and Channer KS: The normal range for
inter-arm differences in blood pressure. Age Ageing. 28:537–542.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chue CD, Edwards NC, Ferro CJ, Steeds RP
and Townend JN: Reduction of blood pressure already in the normal
range further regresses left ventricular mass. Heart. 96:10802010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Colquitt JL and D'Orazio JA: Intracranial
hemorrhage and a white blood cell count of almost 1 million
cells/muL. J Pediatr. 162:2142013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Twig G, Afek A, Shamiss A, Derazne E, Tzur
D, Gordon B and Tirosh A: White blood cells count and incidence of
type 2 diabetes in young men. Diabetes Care. 36:276–282. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Troianos CA, Hartman GS, Glas KE, Skubas
NJ, Eberhardt RT, Walker JD and Reeves ST: Councils on
Intraoperative Echocardiography and Vascular Ultrasound of the
American Society of Echocardiography: Guidelines for performing
ultrasound guided vascular cannulation: Recommendations of the
american society of echocardiography and the society of
cardiovascular anesthesiologists. J Am Soc Echocardiogr.
24:1291–1318. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lang RM, Bierig M, Devereux RB,
Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward
J, Shanewise JS, et al: Recommendations for chamber quantification:
A report from the American Society of Echocardiography's Guidelines
and Standards Committee and the Chamber Quantification Writing
Group, developed in conjunction with the European Association of
Echocardiography, a branch of the European Society of Cardiology. J
Am Soc Echocardiogr. 18:1440–1463. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ganau A, Devereux RB, Roman MJ, de Simone
G, Pickering TG, Saba PS, Vargiu P, Simongini I and Laragh JH:
Patterns of left ventricular hypertrophy and geometric remodeling
in essential hypertension. J Am Coll Cardiol. 19:1550–1558. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koren MJ, Devereux RB, Casale PN, Savage
DD and Laragh JH: Relation of left ventricular mass and geometry to
morbidity and mortality in uncomplicated essential hypertension.
Ann Intern Med. 114:345–352. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin KC, Tsao HM, Chen CH and Chou P:
Hypertension was the major risk factor leading to development of
cardiovascular diseases among men with hyperuricemia. J Rheumatol.
31:1152–1158. 2004.PubMed/NCBI
|
|
25
|
Kováčová M and Kiňová S: Arterial
hypertension in gravidity-a risk factor for cardiovascular
diseases. Vnitr Lek. 58:922–927. 2012.(In Czech). PubMed/NCBI
|
|
26
|
Azancot MA, Ramos N, Moreso FJ, Ibernon M,
Espinel E, Torres IB, Fort J and Seron D: Hypertension in chronic
kidney disease: the influence of renal transplantation.
Transplantation. 98:537–542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barreto MS, Reiners AA and Marcon SS:
Knowledge about hypertension and factors associated with the
non-adherence to drug therapy. Rev Lat Am Enfermagem. 22:491–498.
2014.(Article in English, Portuguese, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hachamovitch R, Sonnenblick EH, Strom JA
and Frishman WH: Left ventricular hypertrophy in hypertension and
the effects of antihypertensive drug therapy. Curr Probl Cardiol.
13:375–421. 1988.PubMed/NCBI
|
|
29
|
Eselin JA and Carter BL: Hypertension and
left ventricular hypertrophy: is drug therapy beneficial?
Pharmacotherapy. 14:60–88. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mehta SK, Rame JE, Khera A, Murphy SA,
Canham RM, Peshock RM, de Lemos JA and Drazner MH: Left ventricular
hypertrophy, subclinical atherosclerosis and inflammation.
Hypertension. 49:1385–1391. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsai WC, Lin CC, Huang YY, Chen JY and
Chen JH: Association of increased arterial stiffness and
inflammation with proteinuria and left ventricular hypertrophy in
non-diabetic hypertensive patients. Blood Press. 16:270–275. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu Y, Chen Y, Li D, Li J, Liu X, Cui C and
Yu C: Hypertension, fluid overload and micro inflammation are
associated with left ventricular hypertrophy in maintenance
hemodialysis patients. Ren Fail. 35:1204–1209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Salles GF, Fiszman R, Cardoso CR and
Muxfeldt ES: Relation of left ventricular hypertrophy with systemic
inflammation and endothelial damage in resistant hypertension.
Hypertension. 50:723–728. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cottone S, Nardi E, Mulè G, Vadalà A,
Lorito MC, Riccobene R, Palermo A, Arsena R, Guarneri M and
Cerasola G: Association between biomarkers of inflammation and left
ventricular hypertrophy in moderate chronic kidney disease. Clin
Nephrol. 67:209–216. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fanning NF, Kell MR, Shorten GD, Kirwan
WO, Bouchier-Hayes D, Cotter TG and Redmond HP: Circulating
granulocyte macrophage colony-stimulating factor in plasma of
patients with the systemic inflammatory response syndrome delays
neutrophil apoptosis through inhibition of spontaneous reactive
oxygen species generation. Shock. 11:167–174. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Scapini P, Morini M, Tecchio C, Minghelli
S, Di Carlo E, Tanghetti E, Albini A, Lowell C, Berton G, Noonan DM
and Cassatella MA: CXCL1/macrophage inflammatory protein-2-induced
angiogenesis in vivo is mediated by neutrophil-derived vascular
endothelial growth factor-A. J Immunol. 172:5034–5040. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Droemann D, Hansen F, Aries SP, Braun J,
Zabel P, Dalhoff K and Schaaf B: Neutrophil apoptosis, activation
and anti-inflammatory cytokine response in granulocyte
colony-stimulating factor-treated patients with community-acquired
pneumonia. Respiration. 73:340–346. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tanabe J, Watanabe M, Mue S and Ohuchi K:
Leukocyte-derived neutrophil chemotactic factor-2 produced by
infiltrated leukocytes in allergic inflammation model in rats is
macrophage inflammatory protein-2. Immunol Invest. 24:757–764.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tavares-Murta BM, Lefort J, Cunha FQ,
Ferreira SH and Vargaftig BB: Interference of a neutrophil
recruitment inhibitory factor upon the accumulation of inflammatory
cells and airway hyperreactivity in sensitized guinea-pigs after
intranasal antigen challenge. Br J Pharmacol. 108:538–543. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shen Y, Zhang FQ and Wei X: Truncated
monocyte chemoattractant protein-1 can alleviate cardiac injury in
mice with viral myocarditis via infiltration of mononuclear cells.
Microbiol Immunol. 58:195–201. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ning J, Li YH and Zhang CB: Expression of
monocyte chemoattractant protein-1 in sudden death due to viral
myocarditis and its medicolegal significance. Fa Yi Xue Za Zhi.
25:334–336. 2009.(In Chinese). PubMed/NCBI
|
|
42
|
Halaris A: Inflammation, heart disease,
and depression. Curr Psychiatry Rep. 15:4002013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huston JM and Tracey KJ: The pulse of
inflammation: heart rate variability, the cholinergic
anti-inflammatory pathway and implications for therapy. J Intern
Med. 269:45–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Luttmann-Gibson H, Suh HH, Coull BA,
Dockery DW, Sarnat SE, Schwartz J, Stone PH and Gold DR: Systemic
inflammation, heart rate variability and air pollution in a cohort
of senior adults. Occup Environ Med. 67:625–630. 2010. View Article : Google Scholar : PubMed/NCBI
|
